BiomEdit is an innovation company that discovers, designs, and develops novel probiotics, microbiome derived bioactives, and engineered microbial medicines to address unmet needs in animal health. Our ambition is to create solutions to some of the most important problems in animal agriculture and food security by leveraging the potential of themicrobiome. BiomEdit’s technology is based on a unique platform that utilizes high-throughput sequencing and data analytics to rapidly discover and screen novel probiotic species and bioactive molecules. These can then be engineered to confer thermostability, enhanced production of beneficial metabolites, or expression of immune modulating proteins. These probiotics and microbially-derived compounds represent the next generation of products designed to promote animal health without the use of antibiotics.

Biotechnology

BiomEdit

Aaron Schacht

Nathan Augspurger

Eric Young

Emily Bulian Helmes

Arvind Kumar (Mahajan)

The Leadership Team at BiomEdit spearheads strategic planning and decision-making, ensuring alignment with the company’s mission to innovate in animal health through microbiome-derived solutions. They oversee business development, research initiatives, product development, regulatory compliance, and technological advancements, guiding the company to achieve its goals of addressing critical challenges in animal agriculture and food security.

Leadership Team

About

Team members

Other teams at BiomEdit

Research and Development